Skip to main content

Kovack Advisors, Inc.

Position in MRNA — Moderna, Inc.

CIK 1728321 FT. LAUDERDALE, FL

Position in MRNA

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$527,304
+$136,750 QoQ
Shares Held
10,380
+77.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
19 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in MRNA Over Time

Shares Held

Position Value (USD)

Derivatives in MRNA

reported options exposure · as of Mar 31, 2022
CallValue
$6,890
CallShares
40
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Kovack Advisors, Inc. holds $5,306,795 across 13 Biotechnology names. MRNA ranks #4 (9.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 MRNA
Moderna, Inc.
This page
10,380 $527,304

All Filings in MRNA

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $527,304 10,380
2024-09-30 $390,554 5,844
2024-06-30 $225,387 1,898
2024-03-31 $291,015 2,731
2023-12-31 $269,310 2,708
2023-09-30 $348,087 3,370
2023-06-30 $412,735 3,397
2023-03-31 $755,460 4,919
2022-12-31 $865,229 4,817
2022-09-30 $646,236 5,465
2022-06-30 $770,675 5,395
2022-03-31 $6,890 40
2022-03-31 $1,050,786 6,100
2021-12-31 $1,736,969 6,839
2021-09-30 $3,910,562 10,161
2021-06-30 $1,937,880 8,247
2021-03-31 $1,094,742 8,360
2020-12-31 $892,696 8,545
2020-09-30 $662,361 9,362
2020-06-30 $235,714 3,671